Pharmaceutical Executive-04-01-2011

Issue PDF
Pharmaceutical Executive

April 01, 2011

A Silver Lining

Pharmaceutical Executive

April 01, 2011

Ilogistica has built a brand new warehouse facility with the latest technology to keep up with outsourcing demands

Pharmaceutical Executive
Columns

April 01, 2011

Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help

Pharmaceutical Executive

This loosely populated nation of almost 17 million is considered to be Latin America's economic powerhouse, with a pharmaceutical industry estimated at $1.5 billion

Pharmaceutical Executive

The parnership between academia and industry is evolving. Will it keep innovation at a premium?

Pharmaceutical Executive
Columns

April 01, 2011

These days, learning to strategically do more with less can keep your sales force performing at a high level

Pharmaceutical Executive

Dutch-based DSM N.V. is seeking innovatinve ways to partner through bolstering manufacturing

Pharmaceutical Executive
Columns

April 01, 2011

William Looney, Editor-in-Chief, last month took home the award for "Best Commentary"

Pharmaceutical Executive
Columns

April 01, 2011

Pfizer's Sarah Krug describes what's necessary to bridge the gap between the patient revolution and healthcare provider in the 21st century

Pharmaceutical Executive

April 01, 2011

Espacio Riesco has adapted to the needs of pharma companies with the largest event space in Chile

Pharmaceutical Executive
Columns

April 01, 2011

GSK's Deirdre Connelly puts the focus on four steps to cement a new compliance culture

Pharmaceutical Executive
Columns

April 01, 2011

It can take both a clinical and non-clinical approach to win the differentiation competition

Pharmaceutical Executive

The determination of Pfizer's Freda Lewis-Hall has enabled her to find a ray of hope in every situation she's encountered

Pharmaceutical Executive
From the Editor

April 01, 2011

A true performance culture has to focus on the mundane as much as the sublime

Columns
Pharmaceutical Executive

April 01, 2011

EU leadership on pharma policy leaves many wondering of the right man is at the helm

Pharmaceutical Executive
Columns

April 01, 2011

Courts, Congress review policies and programs shaping drug costs and access